Cardiovascular disease after the age of 65
Cardiovascular disease after the age of 65
Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Cardiovascular disease after the age of 65 years: epidemiology, risk factors, and prevention strategies With increasing age the risk for cardiovascular disease (CVD) is increasing significantly. Particularly in the case of persons aged 65 years and older, these diseases represent one of the main causes of morbidity and mortality. According to recent epidemiological studies, about 50% of people are affected in this age group, of at least one Form of cardiovascular disease. Epidemiological Data Statistics show that heart attacks, strokes, heart failure and arterial diseases occur in older people significantly more likely to be. In Germany, thousands of deaths, and go back a year on, directly or indirectly, to cardiovascular diseases, with the majority of the deceased are over 65 years old. The life expectancy after a heart attack decreases with age, which underlines the need for early prevention. Main Risk Factors Of the modifiable risk factors in older people include: Arterial hypertension: A persistent blood pressure of ≥140/90 mmHg increased the risk of stroke and heart attack. Hyperlipidemia: Increased Werbstoffe, in particular, LDL‑cholesterol >3.0 mmol/l, promote atherosclerosis. Type 2 Diabetes mellitus: An inadequate blood sugar control causes damage to the vascular wall and promotes cardiovascular events. Obesity and lack of physical activity: A BMI ≥30 kg/m 2 and lack of exercise increase the cardiovascular risk. Smoke: tobacco consumption accelerates vascular calcification and increased tendency to Thrombosis. Among the non-modifiable factors, the biological age, gender (men are at risk up to the time of Menopause stronger), and genetic predisposition. Clinical features in older age In elderly patients, the symptoms of heart disease is often atypical. Instead of typical chest pain during heart attack, fatigue, shortness of breath, or confusion can be in the foreground. In addition, a higher probability of co-morbidities such as renal failure, arthritis, or dementia, which complicates the diagnosis and therapy in the elderly. Diagnostics The Diagnostic process includes: History and clinical examination; ECG and Holter; Echocardiography; Laboratory Parameters (Lipid Spectrum Of Blood Sugar, Renal Parameters); if necessary, exercise ECG, or Corona angiography. Therapeutic and preventive measures A multi-modal therapy is essential: Drug therapy: ACE inhibitors, beta-blockers, statins, anticoagulants. Style changes: salt-reduced diet, weight normalization, regular physical activity (for example, 30 minutes per day) life. Blood pressure and blood sugar control: target values: blood pressure <140/85 mmHg, HbA1c <7,5% (customizable). Education and training: at the heart of schools and individual advice to increase therapy adherence. Conclusion Cardiovascular disease in people over 65 years is a significant public health Problem. Through a combined strategy of risk factor Management, early diagnosis and individually tailored therapy, the quality of life and expectancy in this patient group can be significantly improved. Interdisciplinary care and patient‑centeredness are of Central importance.
Minsan, dinadagdagan ng doktor ang base na therapy (mga gamot na kailangang inumin araw-araw) ng mga gamot na iniinom kapag may krisis, kapag ang presyon ay sobrang taas at biglang tumaas. At ang dosis ay pinipili rin nang napaka-indibidwal. Kaya imposible na sabihin kung alin ang pinakamahusay na gamot sa presyon, sa bawat kaso ay magkakaroon ng sariling kombinasyon na bagay sa iyo. Cardiovascular disease after the age of 65. Madalas nagtatanong ang mga tao sa mga botika tungkol sa mga gamot laban sa presyon ng bagong henerasyon na walang side effects. Pero sa totoong buhay, hindi ito nangyayari. Lahat ng epektibong gamot ay may kanya-kanyang side effects. Kailangan mong maglaan ng maraming oras kasama ang iyong doktor para piliin ang tamang grupo ng gamot laban sa high blood pressure para sa'yo.
The collection of high blood pressure buy
Medications for hypertension with a diuretic effect
Cardiovascular disease in adults
Structure of diseases of the cardiovascular System
https://ip4u.ru/blog/blog/posts/14611-warning-of-cardiovascular-diseases.html
https://24snk.ru/articles/2267-the-mortality-due-to-diseases-of-the-circulatory-system.html
Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay. Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
ICD, and cardiovascular diseases: diagnosis and clinical relevance The International Classification of Diseases (ICD), in its current Version, ICD‑11, is a globally-recognised System for the standardized classification of diseases and health-related conditions. Of particular importance is the category of cardiovascular disease (CVD) is one of the leading causes of death in the global present. Classification of cardiovascular diseases in the ICD In the ICD‑11 cardiovascular diseases systematically in several sub-groups, in order to enable a precise diagnosis and documentation. Among the key categories: High blood pressure (Hypertension): coded under BC60 to BC63, including primary and secondary forms. Coronary heart disease (CHD): classified under BB50 to BB54, including BB50.0 for the stable Angina pectoris and BB 51 for acute myocardial infarction. Heart failure: classified as BB60 (acute) and BB61 (chronic heart failure). Arrhythmias: under BC80 to BC8Z summarized, including BC81 for atrial fibrillation and BC82 for ventricular fibrillation. Flap-error: encoding in the group BB70 to BB7Z, for example, BB71 for aortic valve stenosis. Cerebrovascular disease, including stroke (BE80–BE8Z), including BE80.0 for ischemic strokes. Diagnostic and epidemiological relevance of the ICD-encoding The exact assignment of cardiovascular diseases to the appropriate ICD codes for a number of areas of vital importance: Statistics and epidemiology: The standard coding, it allows for the comparison of Disease incidence and mortality rates between different regions and countries. This is essential for the planning of health actions and the allocation of resources. Clinical research: A unified classification is a prerequisite for the conduct of clinical trials, meta-analyses and long-term observations. Billing and insurance: In many health systems, the ICD form‑codes as the basis for the billing of medical services and to the processing of insurance claims. Quality assurance: The systematic recording of diagnoses helps to monitor the quality of medical care and to improve it. Challenges and perspectives Despite its advantages, the ICD‑coding also presents challenges. These include the complexity of the coding system, the need for regular training of medical personnel, as well as adapting to new scientific findings. The continuous development of the ICD, including the Integration of genetic and molecular data, will improve in the future, the precision of the diagnosis and personalized treatment approaches support. Conclusion The ICD plays diseases a Central role in the systematic detection and classification of cardiovascular. Your application promotes international comparability of data that supports clinical research and improved the care of patients around the world. The ongoing development of the system is necessary in order to progress in medicine.